SENSEX down over 450 points, NIFTY50 hovers around 25,900; Vodafone Idea, PB Fintech, Dr Reddy's Labs, Sagility among buzzing stocks

The Indian equity benchmarks were trading with a negative bias in noon deals on Thursday, October 30, ahead of monthly expiry of SENSEX October futures and option contracts. The SENSEX fell as much as 530 points and NIFTY59 index briefly dropped below its important psychological level of 25,900 dragged down by losses in index heavyweights like Bharti Airtel, HDFC Bank, Reliance Industries, Infosys, ICICI Bank and Bajaj Finance.

As of 12:24 pm, the SENSEX was down 408 points at 84,588 and NIFTY50 index declined 132 points to 25,920.

"We have received a Notice of Non-Compliance (NON) from Pharmaceutical Drugs Directorate, Canada, regarding our Abbreviated New Drug Submission (ANDS) for Semaglutide Injection. The NON outlines requests for additional information & clarifications on specific aspects of the submission. We will submit a response at the earliest and well within the stipulated time period," Dr Reddy's Labs said in an exchange filing.

Semaglutide is an injectable medication used to treat type 2 diabetes and assist with chronic weight management. Sold under the brand names Ozempic and Wegovy, it is a once-weekly subcutaneous injection that helps regulate blood sugar and decrease appetite.

"We remain confident in the quality, safety and comparability of our proposed product and remain committed to making this important therapy available to patients in Canada and other markets at the earliest. We appreciate the continued support of our stakeholders and will share further updates as appropriate," Dr Reddy's Labs added.

The Bengaluru-based company’s consolidated net profit increased 114.5% to ₹251 crore for the July to September quarter of financial year 2025-26 as compared to ₹117 crore in the same period of the previous fiscal year.

The firm’s revenue from operations surged 25% year-on-year (YoY) to ₹1,658 crore in Q2 FY26 in contrast to ₹1,325 crore in the corresponding quarter of the previous financial year.

Sagility’s earnings before interest, tax, depreciation, and amortisation (EBITDA) also rose 38% to ₹416 crore for Q2 FY26 as compared to ₹301 crore in Q2 FY25.

Trading volume in Sagility shares spiked by 8 times to 40.58 crore shares compared with an average trading volume of 5.17 crore shares.

The Supreme Court’s order allowing the government to review the adjusted gross revenue (AGR) dues applies only to the additional dues from 2016–17, according to the order copy. Earlier, on October 27, reports said the Centre was open to reconsidering Vodafone Idea’s request in the AGR case, and the Court allowed it since the matter falls under the government’s policy domain.

Thursday’s order specifically applies to Vodafone Idea due to the unique circumstances of its case.

VIL has sought a direction from the DoT to "comprehensively reassess and reconcile all AGR dues for the period up to FY 2016-17 following the 'Deduction Verification Guidelines'" dated February 3, 2020.

PB Fintech, which operates Policybazaar and Paisabazaar online portals, post market hours on Wednesday reported net profit of ₹135 crore in the second quarter of current financial year, marking an increase of 165% from ₹51 crore in the same period last year.

Its revenue from operations in July-September period advanced 38% to ₹1,614 crore from ₹1,167 crore.

PB Fintech reported strong operational performance as it reported an operational profit of ₹98 crore against operational loss of ₹8 crore.

The company's total insurance premium for the quarter came in at ₹7,605 crore, up 40% year on year (YoY) and 15% quarter on quarter (QoQ), led by growth in online new protection business at 44% YoY, PB Fintech said in an exchange filing.

BHEL's consolidated net profit skyrocketed 254% to ₹375 crore for the July to September quarter of financial year 2025-26 as compared to ₹106 crore in the same period of the previous fiscal year.

The firm’s revenue from operations surged 14% year-on-year (YoY) to ₹7,512 crore in Q2 FY26 in contrast to ₹6,584 crore in the corresponding quarter of the previous financial year.

In the Q2FY26, the company’s consolidated revenue jumped 10% YoY to ₹67984 crore as against ₹61,55 crore in the same period last year. The international business contributed 56% of the revenue for the quarter, up from 52% in the previous year.

On the operational front, the company’s EBITDA jumped 7% YoY to ₹6,806 crore as against ₹6,362 crore with a 30 bps EBITDA margin contraction at 10%. The operational costs jumped 13% YoY to ₹61,178 crore as against ₹55193 crore in the same period last year.

Travel tech platform Ixigo (Le Travenues Technology Limited) on Wednesday reported a consolidated loss of ₹3.46 crore for the September quarter. The company had earned a net profit of ₹13.1 crore a year ago, a regulatory filing said.

It has recorded a one-off ESOP expense of ₹26.7 crore during the quarter.

"Profit before tax, share of loss of associates and exceptional items are at ₹2.5 crore in Q2 FY26, which included a one-off ESOP expense of ₹26.9 crore, and excluding the impact of this one-off was ₹24.4 crore...," ixigo stated.